Human T cell lymphotropic virus type 1 (HTLV-1) infection increases the CD4 count in human immunodeficiency virus type 1 (HIV-1) infected patients submitted to antiretroviral therapy (ARV) by Filipe FA Rego et al.
POSTER PRESENTATION Open Access
Human T cell lymphotropic virus type 1 (HTLV-1)
infection increases the CD4 count in human
immunodeficiency virus type 1 (HIV-1) infected
patients submitted to antiretroviral therapy (ARV)
Filipe FA Rego1,2, Luiz CJ Alcantara1*, Tulio de Oliveira2
From 16th International Conference on Human Retroviruses: HTLV and Related Viruses
Montreal, Canada. 26-30 June 2013
To understand the impact of HTLV-1 in the CD4 counts
in HIV coinfected patients from KwaZulu-Natal, 382
HIV-1 plasma samples with ARV failure were screened
for HTLV-1. Out of 382 samples, eight were reactive in
the EIA and seven were confirmed as HTLV-1 positive
by PCR. The data from those patients was obtained in
the RegaDB and was analyzed regarding the CD4 count
using the STATA software. The prevalence of coinfection
was 1.8% (7/382). The baseline CD4 count did not show
statistical difference between groups before treatment.
The overall CD4 count median during the ARV in coin-
fected patients (301cells/uL) was higher than in HIV-1
infected patients (232cells/uL p=0.0002). The CD4 count
did not behave different between the groups along the
time. This observation might be due to the higher treat-
ment time in coinfected patients (median 1764days vs.
1459days, p<0.0001), provided that in the end of therapy
they were failing on the ARV but the paired analyze with
viral load must be done whereas there is an inverse corre-
lation between CD4 count and viral load. There was no
difference regarding the age and gender between the
groups. HIV-1/HTLV-1 co-infection seems to change the
CD4 count ratio between positive and negative indivi-
duals on ARV.
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